Po‐Liang Lu

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 371 citations · Full text

Hiv/aids Counselling, Treatment And Prevention, Week 48 +14

Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

Po‐Liang Lu, Yung-Ching Liu, Han Siong Toh et al. · International Journal of Antimicrobial Agents · 2012 · 199 citations

Urinary Tract Infections, Antimicrobial Susceptibility, Antibiotics +12

Proteus mirabilis urinary tract infection and bacteremia: Risk factors, clinical presentation, and outcomes

Chi‐Yu Chen, Yen‐Hsu Chen, Po‐Liang Lu et al. · Journal of Microbiology Immunology and Infection · 2012 · 167 citations

Urological Research, Urology, Voiding Dysfunction +9

Risk Factors and Molecular Analysis of Community Methicillin-Resistant <i>Staphylococcus aureus</i> Carriage

Po‐Liang Lu, Lien-Chun Chin, Chien‐Fang Peng et al. · Journal of Clinical Microbiology · 2005 · 137 citations · Full text

Simple Strategy for Rapid and Sensitive Detection of Avian Influenza A H7N9 Virus Based on Intensity-Modulated SPR Biosensor and New Generated Antibody

Ying-Feng Chang, Wen‐Hung Wang, Yi-Wei Hong et al. · Analytical Chemistry · 2018 · 129 citations

Viral Diagnostics, Immunology, Influenza Vaccines +16